Generic Ribavirin Labels Will Carve Out Rebetol/PEG-Intron Indication
Executive Summary
Three Rivers Pharmaceuticals is amending its ribavirin ANDA to remove references to an 800 mg dose appearing in Schering-Plough's Rebetol labeling
You may also be interested in...
Ribavirin ANDAs Clear FDA; Schering Goes Generic Too
Three Rivers/Par, Sandoz and Schering-Plough are launching their ribavirin generics at a 10% discount to Schering's Rebetol
Ribavirin ANDAs Clear FDA; Schering Goes Generic Too
Three Rivers/Par, Sandoz and Schering-Plough are launching their ribavirin generics at a 10% discount to Schering's Rebetol
Par Generic Ribavirin Launch Expected In “Weeks”; ANDA Is “Approvable”
Par is forecasting a launch of generic Rebetol (ribavirin) in the first quarter following a Feb. 22 FDA "approvable" letter